Discovery of DS-1093a: An oral hypoxia-inducible factor prolyl hydroxylase inhibitor for the treatment of renal anemia.
Tanaka N, Fukuda T, Takano R, Sasaki K, Tsuji T, Goto R, Kuribayashi T, Yamaguchi K, Niitsu Y, Ishii K, Hashimoto M, Takahashi S, Obayashi H.
Tanaka N, et al. Among authors: hashimoto m.
Bioorg Med Chem Lett. 2024 Oct 1;111:129891. doi: 10.1016/j.bmcl.2024.129891. Epub 2024 Jul 15.
Bioorg Med Chem Lett. 2024.
PMID: 39019240